RxDoctor Payments Data

Lacy Moore

Family · Wartrace, TNNPI 1457682874

Payments from drug & device makers

$1,919in general payments, 2019–2025

Across 100 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$355
  • Lilly USA, LLC$308
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$277
  • Novo Nordisk$212
  • Xeris Pharmaceuticals, Inc.$192
  • GSK$96
  • plus $479 from 14 others

What the payments were for

  • Food & beverage$1,88698%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,919 in reported general payments places this provider in the 75th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide121$145,545
OzempicSemaglutide59$92,682
Trelegy ElliptaFluticasone/Umeclidin/Vilanter64$70,226
FarxigaDapagliflozin Propanediol47$48,226
LinzessLinaclotide29$36,797
RexultiBrexpiprazole24$33,993
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$33,190
VraylarCariprazine Hcl24$30,705
JardianceEmpagliflozin32$27,943
Tresiba Flextouch U-100Insulin Degludec29$24,291
UbrelvyUbrogepant11$17,798
EliquisApixaban13$13,229
Lantus SolostarInsulin Glargine,hum.Rec.Anlog59$7,558
EntrestoSacubitril/Valsartan12$6,250
Albuterol Sulfate HfaAlbuterol Sulfate84$2,375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$308$145,545121 claims
Novo NordiskOzempic$212$92,68259 claims
AbbVieLinzess, Vraylar, Ubrelvy$355$85,30164 claims
AstraZenecaFarxiga, Breztri Aerosphere$36$81,41676 claims
GSKTrelegy Ellipta$96$70,22664 claims
Otsuka America Pharmaceutical, Inc.Rexulti$17$33,99324 claims
PfizerEliquis$93$13,22913 claims
NovartisEntresto$43$6,25012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,706 family providers in Tennessee.

Other family in Wartrace

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →